Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Vertical Nanowire Arrays Offers Potential for Faster Diagnoses

By LabMedica International staff writers
Posted on 24 Oct 2013
Protein microarrays are valuable tools for protein analysis and a method that will make the process faster, cheaper and more accurate has been developed. More...


Reducing spot sizes from microscale to nanoscale facilitates miniaturization of platforms and consequently decreased material consumption, but faces inherent challenges in the reduction of fluorescent signals and compatibility with complex solutions.

Scientists at the University of Copenhagen (Denmark) have constructed vertical arrays of nanowires (NWs) that can overcome several bottlenecks of using nanoarrays for extraction and analysis of proteins. The majority of protein microarray applications use fluorescence detection of proteins due to the simplicity of detection, availability of fluorophores with a wide range of properties and possibilities of multiplexing, although label-free techniques are emerging as interesting alternatives.

The investigators used ordered arrays of vertically aligned indium arsenide (InAs) NW arrays to perform bioanalytical assays on protein nanospots. The three dimensional structure of the NWs substantially increases the amount of protein that can be immobilized on each feature of the array, thereby increasing the signal from nanometer-sized spots. Furthermore, the high aspect ratio of the NWs allows the detection of signals several micrometers away from the surface of the chip, thus rendering passivation of the surface between the NWs unnecessary.

The nanowires stand up like a little forest, creating a much greater surface area to hold the proteins because they can attach to all sides of the nanowire. When examining the proteins, the nanowires can be reused by performing a multiple tests on the same protein. This simplifies the workflow in the laboratory greatly in comparison to the conventional method, where scientists have to start over with a new plate to hold the proteins every time they perform a new analysis. In this way, the method helps to make the diagnostic process more environmentally friendly and economically viable for use.

Katrine R. Rostgaard, a PhD student at the Nano-Science Center of the University and lead author of the study said, “We have developed a method in which we optimize the analysis of the proteins. A central point of this method is the use of nanowires to hold the proteins while we analyze them. It is unique. With greater area, we can hold more proteins at once. This makes it possible to measure for multiple biomarkers simultaneously and it increases the signal, thereby providing a better quality of diagnosis.” The study was published on August 22, 2013, in the journal Nanoscale.

Related Links:

University of Copenhagen



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.